{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:51:30Z","timestamp":1791510690809,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["813284"],"award-info":[{"award-number":["813284"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.neo.2023.100903","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T18:18:06Z","timestamp":1683224286000},"page":"100903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Mitochondrial rewiring drives metabolic adaptation to NAD(H) shortage in triple negative breast cancer cells"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0919-2542","authenticated-orcid":false,"given":"Agata Sofia Assuncao","family":"Carreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0803-1042","authenticated-orcid":false,"given":"Silvia","family":"Ravera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Zucal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natthakan","family":"Thongon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1111-9915","authenticated-orcid":false,"given":"Caffa","family":"Irene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Astigiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4591-3260","authenticated-orcid":false,"given":"Nadia","family":"Bertola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Buongiorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Roccuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9571-4257","authenticated-orcid":false,"given":"Barbara","family":"Pardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Nencioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santina","family":"Bruzzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1652-3415","authenticated-orcid":false,"given":"Alessandro","family":"Provenzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2023.100903_bib0001","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neo.2023.100903_bib0002","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.neo.2023.100903_bib0003","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1158\/0008-5472.CAN-16-2074","article-title":"Modeling the genetic regulation of cancer metabolism: interplay between glycolysis and oxidative phosphorylation","volume":"77","author":"Yu","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2023.100903_bib0004","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","article-title":"Mitochondrial metabolism as a target for cancer therapy","volume":"32","author":"Vasan","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.neo.2023.100903_bib0005","first-page":"139","article-title":"Mitochondria and cancer","volume":"176","author":"Diering","year":"2018","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neo.2023.100903_bib0006","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/ncb3039","article-title":"Phosphorylation to promote metastasis","volume":"16","author":"LeBleu","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neo.2023.100903_bib0007","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3390\/cells8111371","article-title":"Regulation of glucose metabolism by NAD+ and ADP-ribosylation","volume":"8","author":"Hopp","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.neo.2023.100903_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110157","article-title":"NAD kinase sustains lipogenesis and mitochondrial metabolism through fatty acid synthesis","volume":"37","author":"Xu","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.neo.2023.100903_bib0009","doi-asserted-by":"crossref","first-page":"12967","DOI":"10.1074\/jbc.M112.396796","article-title":"Cofactor balance by nicotinamide nucleotide transhydrogenase (NNT) coordinates reductive carboxylation and glucose catabolism in the tricarboxylic acid (TCA) cycle","volume":"288","author":"Gameiro","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neo.2023.100903_bib0010","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.bbapap.2009.10.022","article-title":"SIRT1-dependent regulation of chromatin and transcription: linking NAD+ metabolism and signaling to the control of cellular functions","volume":"1804","author":"Zhang","year":"2010","journal-title":"Biochim. Biophys. Acta - Prot. Proteomics"},{"key":"10.1016\/j.neo.2023.100903_bib0011","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1039\/D1SC06256E","article-title":"Discovery of an NAD+analogue with enhanced specificity for PARP1","volume":"13","author":"Zhang","year":"2022","journal-title":"Chem. Sci."},{"key":"10.1016\/j.neo.2023.100903_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.01187","article-title":"The Multi-faceted Ecto-enzyme CD38: roles in immunomodulation, cancer, aging, and metabolic diseases","volume":"10","author":"Hogan","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neo.2023.100903_bib0013","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1158\/0008-5472.CAN-12-3831","article-title":"The endogenous tryptophan metabolite and NAD+ precursor quinolinic acid confers resistance of gliomas to oxidative stress","volume":"73","author":"Sahm","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2023.100903_bib0014","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0021-9258(18)64789-1","article-title":"Biosynthesis of diphosphopyridine nucleotide","volume":"233","author":"Preiss","year":"1958","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neo.2023.100903_bib0015","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0092-8674(04)00416-7","article-title":"Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a preiss-handler independent route to NAD in fungi and humans it became clear that Sir2 and Sir2-related enzymes termed Sirtuins deacetylate lysine residues with consumpt","volume":"117","author":"Bieganowski","year":"2004","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.neo.2023.100903_bib0016","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3390\/nu13051665","article-title":"Advances in nad-lowering agents for cancer treatment","volume":"13","author":"Ghanem","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.neo.2023.100903_bib0017","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.aac4854","article-title":"NAD+ in aging, metabolism, and neurodegeneration","volume":"350","author":"Verdin","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.neo.2023.100903_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-022-03315-9","article-title":"Tumors carrying BRAF-mutations over-express NAMPT that is genetically amplified and possesses oncogenic properties","volume":"20","author":"Audrito","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.neo.2023.100903_bib0019","doi-asserted-by":"crossref","first-page":"7859","DOI":"10.1007\/s13277-015-3506-z","article-title":"Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin\/survivin DEx3 expression","volume":"36","author":"Sawicka-Gutaj","year":"2015","journal-title":"Tumor Biol"},{"key":"10.1016\/j.neo.2023.100903_bib0020","first-page":"1251","article-title":"Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil","volume":"26","author":"Bi","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.neo.2023.100903_bib0021","first-page":"6648","article-title":"Expression of NAMPT is associated with breast invasive ductal carcinoma development and prognosis","volume":"15","author":"Zhou","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.neo.2023.100903_bib0022","doi-asserted-by":"crossref","DOI":"10.1038\/s41389-020-00264-0","article-title":"Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) with OT-82 induces DNA damage, cell death, and suppression of tumor growth in preclinical models of Ewing sarcoma","volume":"9","author":"Gibson","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.neo.2023.100903_bib0023","doi-asserted-by":"crossref","first-page":"16451","DOI":"10.18632\/oncotarget.24731","article-title":"Cross resistance to diverse anticancer nicotinamide phosphoribosyltransferase inhibitors induced by FK866 treatment","volume":"9","author":"Ogino","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2023.100903_bib0024","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.21873\/anticanres.13859","article-title":"Association of ABC transporter with resistance to FK866, a NAMPT inhibitor, in human colorectal cancer cells","volume":"39","author":"Ogino","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.neo.2023.100903_bib0025","doi-asserted-by":"crossref","DOI":"10.1186\/s40170-018-0174-7","article-title":"Cancer cell metabolic plasticity allows resistance to NAMPT inhibition but invariably induces dependence on LDHA","volume":"6","author":"Thongon","year":"2018","journal-title":"Cancer Metabol"},{"key":"10.1016\/j.neo.2023.100903_bib0026","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ygeno.2018.12.012","article-title":"Genomic and tumor biological aspects of the anticancer nicotinamide phosphoribosyltransferase inhibitor FK866 in resistant human colorectal cancer cells","volume":"111","author":"Ogino","year":"2019","journal-title":"Genomics"},{"key":"10.1016\/j.neo.2023.100903_bib0027","doi-asserted-by":"crossref","first-page":"e7897","DOI":"10.1371\/journal.pone.0007897","article-title":"Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE","volume":"4","author":"Bruzzone","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2023.100903_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101618","article-title":"The passage from bone marrow niche to bloodstream triggers the metabolic impairment in Fanconi Anemia mononuclear cells","volume":"36","author":"Cappelli","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.neo.2023.100903_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153729","article-title":"The human fetal and adult stem cell secretome can exert cardioprotective paracrine effects against cardiotoxicity and oxidative stress from cancer treatment","volume":"13","author":"Villa","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2023.100903_bib0030","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji\u202f: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.neo.2023.100903_bib0031","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6626286","article-title":"Photobiomodulation and oxidative stress\u202f: 980nm diode laser light regulates mitochondrial activity and reactive oxygen species production","author":"Amaroli","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.neo.2023.100903_bib0032","article-title":"Structural basis for resistance to diverse classes of NAMPT inhibitors","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2023.100903_bib0033","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13045-022-01313-4","article-title":"Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management","volume":"15","author":"Jin","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.neo.2023.100903_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2017.00796","article-title":"Presenilin 2-dependent maintenance of mitochondrial oxidative capacity and morphology","volume":"8","author":"Contino","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.neo.2023.100903_bib0035","first-page":"1537","article-title":"The Oxidation of Fatty Acids Combined with Albumin by Isolated Rat Liver","volume":"241","author":"Bj\u00f6rntorp","year":"1966","journal-title":"Mitochondria"},{"key":"10.1016\/j.neo.2023.100903_bib0036","first-page":"1","article-title":"Linking metabolic reprogramming to therapy resistance in cancer","volume":"1868","author":"Morandi","year":"2017","journal-title":"BBA - Rev. Cancer"},{"key":"10.1016\/j.neo.2023.100903_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2008.01.019","article-title":"Anticancer agent CHS-828 inhibits cellular synthesis of NAD","volume":"367","author":"Olesen","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neo.2023.100903_bib0038","doi-asserted-by":"crossref","first-page":"59950","DOI":"10.18632\/oncotarget.19048","article-title":"The molecular mechanisms of chemoresistance in cancers","volume":"8","author":"Zheng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2023.100903_bib0039","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.bbrc.2017.07.143","article-title":"Identification of novel resistance mechanisms to NAMPT inhibition via the de novo NAD+ biosynthesis pathway and NAMPT mutation","volume":"491","author":"Guo","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neo.2023.100903_bib0040","article-title":"Nicotinic acid phosphoribosyltransferase regulates cancer cell metabolism, susceptibility to NAMPT inhibitors and DNA repair","volume":"3079","author":"Piacente","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2023.100903_bib0041","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1593\/neo.131718","article-title":"Supplementation of nicotinic acid with NAMPT inhibitors results in loss of in vivo efficacy in NAPRT1-deficient tumor models","volume":"15","author":"O'Brien","year":"2013","journal-title":"Neoplasia (United States)"},{"key":"10.1016\/j.neo.2023.100903_bib0042","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1158\/1078-0432.CCR-13-1186","article-title":"Loss of NAPRT1 expression by tumor-specific promoter methylation provides a novel predictive biomarker for NAMPT inhibitors","volume":"19","author":"Shames","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2023.100903_bib0043","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41586-019-1150-2","article-title":"NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling","volume":"569","author":"Chowdhry","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neo.2023.100903_bib0044","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1096\/fj.202000767R","article-title":"Mitochondrial spare respiratory capacity: mechanisms, regulation, and significance in non-transformed and cancer cells","volume":"34","author":"Marchetti","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.neo.2023.100903_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cddis.2015.202","article-title":"Mitochondrial complex II is a source of the reserve respiratory capacity that is regulated by metabolic sensors and promotes cell survival","volume":"6","author":"Pfleger","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neo.2023.100903_bib0046","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1158\/1535-7163.MCT-18-0766","article-title":"Respiratory capacity and reserve predict cell sensitivity to mitochondria inhibitors: Mechanism-based markers to identify metformin-responsive cancers","volume":"18","author":"Teh","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.neo.2023.100903_bib0047","article-title":"Metabolic rewiring in drug resistant cells exhibit higher OXPHOS and fatty acids as preferred major source to cellular energetics","volume":"1861","author":"Salunkhe","year":"2020","journal-title":"Biochim. Biophys. Acta - Bioenergy"},{"key":"10.1016\/j.neo.2023.100903_bib0048","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.neo.2023.100903_bib0049","first-page":"1055","article-title":"ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells","volume":"53","author":"Xu","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.neo.2023.100903_bib0050","doi-asserted-by":"crossref","first-page":"30472","DOI":"10.18632\/oncotarget.5401","article-title":"High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant","volume":"6","author":"Farnie","year":"2015","journal-title":"Oncotarget"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558623000283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558623000283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:12:58Z","timestamp":1761484378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558623000283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":50,"alternative-id":["S1476558623000283"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2023.100903","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial rewiring drives metabolic adaptation to NAD(H) shortage in triple negative breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2023.100903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100903"}}